Order Processing
T: +49 (89) 45 08 08 78-88
F: +49 (89) 45 08 08 78-60
sales@bendalis.com
Drug Safety
In case you want to report a suspected case of Adverse Drug Event, you can write an E-Mail directly to ams@bendalis.com
With regards to drug safety, we are interested in all reports that are associated with our products, irrespective of the severity of the Adverse Drug Reaction and whether or not the Adverse Reaction is already specified in the Summary of Product Characteristics (SPC) / Package Leaflet (PL).
You can also contact us by phone or post:
Bendalis GmbH
Keltenring 17
82041 Oberhaching
Germany
• By phone during business hours (9:00-17:00 on business days):
+49 89 45080878-0
• By phone outside business hours: +49 89 45080878-96
Please have the following information ready for telephone messages:
1. Name of the product / preparation
2. Batch number (Ch.-B. or LOT), if known
3. Details of the adverse reaction(s)
4. Information about the patient (age, gender and/or initials)
5. Name and address of the reporter for possible queries
Liability for Contents
As service providers, we are liable for own contents of these websites according to Sec. 7, paragraph 1 German Telemedia Act (TMG). However, according to Sec. 8 to 10 German Telemedia Act (TMG), service providers are not obligated to permanently monitor submitted or stored information or to search for evidences that indicate illegal activities.
Legal obligations to removing information or to blocking the use of information remain unchallenged. In this case, liability is only possible at the time of knowledge about a specific violation of law. Illegal contents will be removed immediately at the time we get knowledge of them.
Liability for Links
Our offer includes links to external third party websites. We have no influence on the contents of those websites, therefore we cannot guarantee for those contents. Providers or administrators of linked websites are always responsible for their own contents.
The linked websites had been checked for possible violations of law at the time of the establishment of the link. Illegal contents were not detected at the time of the linking. A permanent monitoring of the contents of linked websites cannot be imposed without reasonable indications that there has been a violation of law. Illegal links will be removed immediately at the time we get knowledge of them.
Copyright
Contents and compilations published on these websites by the providers are subject to German copyright laws. Reproduction, editing, distribution as well as the use of any kind outside the scope of the copyright law require a written permission of the author or originator. Downloads and copies of these websites are permitted for private use only.
The commercial use of our contents without permission of the originator is prohibited.
Copyright laws of third parties are respected as long as the contents on these websites do not originate from the provider. Contributions of third parties on this site are indicated as such. However, if you notice any violations of copyright law, please inform us. Such contents will be removed immediately.
Site Notice
Information pursuant to § 5 TMG
Bendalis GmbH
Keltenring 17
82041 Oberhaching
Handelsregister: HRB 162575
Registration court: Munich District Court – Amtsgerich München
Represented by the managing directors:
Dr. Wolfgang Burger
Dr. Dirk Hütten
Contact
Phone: +49 89 45080878-70
Telefax: +49 89 45080878-80
E-mail: info@bendalis.com
VAT ID
Sales tax identification number according to § 27 a of the Sales Tax Law:
DE 248820249
Supervisory authority
Herstellerlaubnis:
Regierung von Oberbayern
Zulassung Produkte: Bundesinstitut für Arzneimittel und Medizinprodukte
Herstellerlaubnis:
Regierung von Oberbayern
Sachgebiet 53.2
80534 München
Zulassung Produkte:
Bundesinstitut für Arzneimittel und Medizinprodukte
Kurt-Georg-Kiesinger-Allee 3
53175 Bonn
Responsible for the content according to § 55(2) RStV
Dr. Wolfgang Burger
Dr. Dirk Hütten
Bendalis GmbH
Keltenring 17
82041 Oberhaching
EU dispute resolution
The European Commission provides a platform for online dispute resolution (ODR): https://ec.europa.eu/consumers/odr.
Our e-mail address can be found above in the site notice.
We are not willing or obliged to participate in dispute resolution proceedings before a consumer arbitration board.